An enzymatic assay of MAO-A activity in AD brain tissue showed an increase or no change in several brain regions [17], while another report using similar assay methods indicated a decrease in MAO-A activity in the prefrontal cortex [18]. The gene discussed is MAOA; the disease is Alzheimer disease.